260 related articles for article (PubMed ID: 16585872)
1. Long-term follow-up results of selective laryngeal adductor denervation-reinnervation surgery for adductor spasmodic dysphonia.
Chhetri DK; Mendelsohn AH; Blumin JH; Berke GS
Laryngoscope; 2006 Apr; 116(4):635-42. PubMed ID: 16585872
[TBL] [Abstract][Full Text] [Related]
2. Transoral laser ventricular fold resection and thyroarytenoid myoneurectomy for adductor spasmodic dysphonia: long-term outcome.
Su CY; Lai CC; Wu PY; Huang HH
Laryngoscope; 2010 Feb; 120(2):313-8. PubMed ID: 20013850
[TBL] [Abstract][Full Text] [Related]
3. Lidocaine block of the recurrent laryngeal nerve in adductor spasmodic dysphonia: a multidimensional assessment.
Smith ME; Roy N; Wilson C
Laryngoscope; 2006 Apr; 116(4):591-5. PubMed ID: 16585864
[TBL] [Abstract][Full Text] [Related]
4. Long-term voice handicap index after type II thyroplasty using titanium bridges for adductor spasmodic dysphonia.
Sanuki T; Yumoto E; Kodama N; Minoda R; Kumai Y
Auris Nasus Larynx; 2014 Jun; 41(3):285-9. PubMed ID: 24369905
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting patient perception of dysphonia caused by benign vocal fold lesions.
Behrman A; Sulica L; He T
Laryngoscope; 2004 Oct; 114(10):1693-700. PubMed ID: 15454756
[TBL] [Abstract][Full Text] [Related]
7. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
Zwirner P; Murry T; Swenson M; Woodson GE
Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal study of voice before and after phonosurgery for removal of a polyp.
Stajner-Katusić S; Horga D; Zrinski KV
Clin Linguist Phon; 2008; 22(10-11):857-63. PubMed ID: 18608247
[TBL] [Abstract][Full Text] [Related]
9. Validity and reliability of the glottal function index.
Bach KK; Belafsky PC; Wasylik K; Postma GN; Koufman JA
Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):961-4. PubMed ID: 16301366
[TBL] [Abstract][Full Text] [Related]
10. Functional reinnervation of vocal folds after selective laryngeal adductor denervation-reinnervation surgery for spasmodic dysphonia.
DeConde AS; Long JL; Armin BB; Berke GS
J Voice; 2012 Sep; 26(5):602-3. PubMed ID: 22516313
[TBL] [Abstract][Full Text] [Related]
11. Vocal fold augmentation by autologous fat injection with lipostructure procedure.
Cantarella G; Mazzola RF; Domenichini E; Arnone F; Maraschi B
Otolaryngol Head Neck Surg; 2005 Feb; 132(2):239-43. PubMed ID: 15692533
[TBL] [Abstract][Full Text] [Related]
12. Voice handicap evaluation after supracricoid partial laryngectomy.
Makeieff M; de la Breteque A; Guerrier B; Giovanni A
Laryngoscope; 2009 Apr; 119(4):746-50. PubMed ID: 19205015
[TBL] [Abstract][Full Text] [Related]
13. Voice handicap index results for older patients with adductor spasmodic dysphonia.
Wingate JM; Ruddy BH; Lundy DS; Lehman J; Casiano R; Collins SP; Woodson GE; Sapienza C
J Voice; 2005 Mar; 19(1):124-31. PubMed ID: 15766857
[TBL] [Abstract][Full Text] [Related]
14. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia.
Fritzell B; Hammarberg B; Schiratzki H; Haglund S; Knutsson E; Mårtensson A
J Voice; 1993 Jun; 7(2):172-8. PubMed ID: 8353632
[TBL] [Abstract][Full Text] [Related]
16. Impact in vocal quality in partial myectomy and neurectomy endoscopic of thyroarytenoid muscle in patients with adductor spasmodic dysphonia.
Tsuji DH; Chrispim FS; Imamura R; Sennes LU; Hachiya A
Braz J Otorhinolaryngol; 2006; 72(2):261-6. PubMed ID: 16951863
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of Parkinson's-related dysphonia.
Sewall GK; Jiang J; Ford CN
Laryngoscope; 2006 Oct; 116(10):1740-4. PubMed ID: 17003722
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of surgical treatment of vocal fold nodules.
Béquignon E; Bach C; Fugain C; Guilleré L; Blumen M; Chabolle F; Wagner I
Laryngoscope; 2013 Aug; 123(8):1926-30. PubMed ID: 23757348
[TBL] [Abstract][Full Text] [Related]
19. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results.
Adams SG; Hunt EJ; Charles DA; Lang AE
J Otolaryngol; 1993 Jun; 22(3):171-5. PubMed ID: 8371328
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results.
Paniello RC; Barlow J; Serna JS
Laryngoscope; 2008 Mar; 118(3):564-8. PubMed ID: 18216744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
